Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Stock Information for GlucoTrack Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GlucoTrack Inc.

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
Glucotrack, Inc. Encourages Shareholders to Vote
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
Glucotrack, Inc. Reminds Shareholders to Vote
Glucotrack to Participate in the Q3 Virtual Investor Summit
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.